CD19 and B-cell non-Hodgkin lymphoma: Their results showed that compared to conventional anti-CD19 CAR T cells, transfection of mRNA encoding TERT in anti-CD19 CAR T cells leads to improved proliferation and persistence in murine xenograft tumor models of human B-cell lymphomas (76).